Oramed Pharmaceuticals Inc.ORMPNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-12.78M
↑ 21% above average
Average (9y)
$-16.14M
Historical baseline
Range
High:$-7.38M
Low:$-40.60M
CAGR
+6.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-12.78M | +18.9% |
| 2023 | $-15.77M | +61.2% |
| 2022 | $-40.60M | -67.6% |
| 2021 | $-24.22M | -106.0% |
| 2020 | $-11.76M | +19.6% |
| 2019 | $-14.63M | -8.2% |
| 2018 | $-13.53M | -25.6% |
| 2017 | $-10.77M | -7.6% |
| 2016 | $-10.01M | -35.6% |
| 2015 | $-7.38M | - |